Inicio・Lista de Acciones・Pulse Biosciences Inc

Pulse Biosciences Inc

Abierto

SectorSanidad

32.79 8.11

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

28.7

Máximo

30.87

Métricas clave
By Trading Economics
Ingresos	-1.1M -19M
Ventas	137K 401K
BPA	-0.241
Margen de beneficios	-4,633.666
Empleados	116
EBITDA	-1.7M -19M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+10.5% upside

Dividendos
By Acuity
Próximas Ganancias	6 ago 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	464M 2B
Apertura anterior	24.68
Cierre anterior	32.79

Noticias sobre sentimiento de mercado

By Acuity

20%

80%

33 / 340 Clasificación en Healthcare

Pulse Biosciences Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

21 jul 2026, 22:51 UTC

Pulse Biosciences Inc shares declined in after-market trading, reversing earlier gains. No specific news was identified to explain the price movement.

20 jul 2026, 19:26 UTC

Shares of Pulse Biosciences Inc. are lower today, reversing earlier gains amid broader market pressure from rising US Treasury yields and geopolitical uncertainties.

Comparación entre iguales

Cambio de precio

Pulse Biosciences Inc previsión

Precio Objetivo

By TipRanks

10.5% repunte

Estimación a 12 Meses

Media 32 USD 10.5%

Máximo 32 USD

Mínimo 32 USD

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Pulse Biosciences Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

1 ratings

Comprar

Mantener

Vender

De acuerdo con 1 analistas que ofrecen calificaciones bursátiles a para Pulse Biosciences Inc Dist en los últimos 3 meses.

Sentimiento

By Acuity

33 / 340 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.